Perovskite solar cells (PSCs) have attracted considerable attention as a competitor technology in solar cells due to the rapid enhancement in their power conversion efficiency (PCE) in recent years. PSCs have several advantages such as their bandgap tunability, lower cost, tolerance of high impurities, protracted diffusion length and wide optical absorption. In this paper, simulation of PSCs with copper oxide as a hole transport material (HTM) and different electron transport materials (ETMs) has been presented. The proposed materials are a replacement to the ordinary hole and ETMs; such as the titanium dioxide and the expensive spiro-OMeTAD. In addition, a comprehensive study for optimizing the features and parameters of the PSCs, such as the thickness and defect density of the perovskite layer, the doping concentrations, and the bandgap energy, has been introduced. The simulation and the performance evaluation of the designed PSCs have been carried out using SCAPS-1D. The results show that mixed halide PSC with zinc oxysulfide as ETM and copper oxide as HTM has an enhanced performance with a PCE of up to 30.82%.

No abstract

Perovskite solar cells (PSCs) have drawn significant consideration as a competing solar cell technology because of the drastic advance in their power conversion efficiency (PCE) over the last two decades. The interfaces between the electron transport layer (ETL) and the absorber layer and between the absorber layer and the hole transport layer (HTL) have a major impact on the performance of the PSCs. In this paper, we have investigated the defect interfaces between ETL/absorber layer and absorber layer/HTL of calibrated experimental lead-based and lead-free PSCs. The influence of the defect interfaces is studied in order to find the optimum value for the maximum possible PCE. While the PCE has not been enhanced considerably for the lead-based, it is boosted from 1.76% to 5.35% for lead-free PSCs. Also, bulk traps were found to have minor role in comparison with interface traps for the lead-free cell while they have a significant impact for the lead-based cell. The results presented in this work would shed some light on designing interface defects of various types of practical PSC structures and demonstrates the crucial impact of the interface defects on lead-free vs lead-based PSCs. All simulation studies are performed by using SCAPS-1D simulator.

Only a few treatments are approved for coronavirus disease‐2019 (COVID‐19) infections, with continuous debate about their clinical impact. Repurposing antiviral treatments might prove the fastest way to identify effective therapy. This trial aimed to evaluate the efficacy and safety of sofosbuvir (SOF) plus daclatasvir (DCV) or ravidasvir (RDV) added to standard care (SOC) for patients with moderate and severe COVID‐19 infection. Multicentre parallel randomized controlled open‐label trial. One hundred and twenty eligible patients with moderate and severe COVID‐19 infection were randomized to one of the study arms. Ten days of treatment with SOF plus DCV or RDV in addition to the standard of care compared to SOC. Follow up in 7 days. Sum of the counted symptoms at 7 and 10 days, mean change in oxygen saturation level, viral negativity, and rate of intensive care unit (ICU) admission. Compared to SOC, the SOF‐DCV group experienced a significantly lower sum of the counted symptoms (fever, headache, generalized aches, or respiratory distress) combined with no evidence of deterioration (ICU admission and mechanical ventilation) on Days 7 and 10 of treatment. Oxygen saturation also significantly improved among the SOF‐DCV group compared to SOC starting from Day 4. The study also showed positive trends regarding the efficacy of SOF‐DCV with a lower incidence of mortality. On the other hand, adding SOF‐RDV to SOC did not show significant improvements in endpoints. The results support the efficacy and safety of SOF‐DCV as an add‐on to SOC for the treatment of moderate to severe COVID‐19 infections.

In this work, the structural, elastic, electronic, thermodynamic, optical, and thermoelectric properties of cubic phase SnTiO3 employing first-principles calculation are examined. The calculations of all parameters via various potentials such as LDA, PBE-GGA, WC-GGA, PBEsol-GGA, mBJ-GGA, nmBJ-GGA, and HSE are performed. The computed band structure yields an indirect bandgap of 1.88 eV with the HSE approach. The optical parameters have been evaluated through absorption, dispersion, and loss function. For cubic phase SnTiO3, the maximum absorption coefficient α(ω) is 173 × 104 (cm)−1 at high energy region 9 eV. The thermoelectric properties of the SnTiO3 have been explored by the Seebeck coefficient, thermal conductivity, and power factor employing the BoltzTrap code with temperature and chemical potential. Furthermore, the thermodynamic quantities under high pressure (0–120 GPa) and temperature (0–1200 K) are also calculated.